Pfizer Japan Obtains Manufacturing Approval Of Gabapentin For Antiepileptic
Main Category: EpilepsyArticle Date: 07 Aug 2006 - 0:00 PDT
email to a friend 
printer friendly 
opinions
| Patient / Public: |  |
5 (2 votes) |
| Healthcare Prof: | |
5 (1 votes) |
Pfizer Japan Inc. has obtained manufacturing approval of Gabapentin on July 26. Gabapentin can be taken in conjunction with other drugs. Since it does not induce drug-metabolizing enzymes, it has proven to be safely taken with other drugs.
Gabapentin is known by product name Neurontin abroad, and is distributed in 91 countries worldwide.
70% of the patients in Japan can control their disease by taking the conventional drug; however 30% suffers from intractable epilepsy that requires multiple drug treatments.
It is expected that the launch of Gabapentin in Japan will improve the quality of life for these patients.
By Aki Tsukioka, JCN Staff Writer
Copyright © 2006 JCN. All rights reserved. A division of Japan Corporate News Network KK.
JCN
Visit our epilepsy section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/48948.php>
APA
http://www.medicalnewstoday.com/releases/48948.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Privacy Policy |
Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
